methylprednisolone has been researched along with verapamil in 40 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (15.00) | 18.7374 |
| 1990's | 3 (7.50) | 18.2507 |
| 2000's | 18 (45.00) | 29.6817 |
| 2010's | 13 (32.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
| Thakker, DR; Troutman, MD | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
| Johans, C; Kinnunen, PK; Söderlund, T; Suomalainen, P | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Sun, Y; Yan, Z | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Chen, X; Lin, X; Skolnik, S; Wang, J | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Caradonna, NP; Hallifax, D; Houston, JB; Turlizzi, E; Zanelli, U | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Fassold, E; Nayler, WG; Yepez, C | 1 |
| Bake, I; Buttazzoni, E; Csongrady, A; Pfänder, C; Schneider, M; Tarmann, H | 1 |
| Kuznetsov, SI; Provotorov, VM | 2 |
| Armstrong, J; Dawidson, I; Diller, K; Lafferty, K; Pratt, P; Rooth, P; Simonsen, R; Täljedal, IB | 1 |
| Bell, JB; Gore, ME; Maitland, JA; McElwain, TJ; Millar, BC; Selby, PJ; Zuiable, A | 1 |
| Bruserud, O; Jørgensen, PF; Sollid, L | 1 |
| Andersen, K; Arnbjerg, J; Fischer Hansen, B; Husum, B; Vejlsted, H | 1 |
| Fujimura, H; Nishiyama, S; Ohmachi, Y; Okumura, F; Toriumi, W; Yoneda, H | 1 |
| Erfurth, A; Evers, S; Frese, A; Husstedt, IW; Lüttmann, RJ | 1 |
| Aungst, BJ; Nakayama, A; Oda, M; Oka, A; Saitoh, H; Takada, M | 1 |
| Dommerich, S; Graumüller, S; Hoff, M; Ostwald, J | 1 |
| Alberca, R; Cayuela, A; Franco, E; Lozano, P; Martínez, E; Mir, P; Montes, E; Navarro, A | 1 |
| Moyssakis, I; Papadopoulos, DP; Votteas, VE | 1 |
| Baskiewicz-Masiuk, M; Gawronska-Szklarz, B; Machalinski, B; Pawlik, A | 1 |
| Achiwa, K; Aungst, BJ; Kobayashi, M; Oda, M; Saikachi, Y; Saitoh, H; Tadano, K; Takahashi, Y; Yamaguchi, M; Yuhki, Y | 1 |
| Riederer, F; Sándor, PS; Selekler, HM; Wöber, C | 1 |
| Bleck, TP; Fletcher, JJ; Kramer, AH; Solenski, NJ | 1 |
| Asghar, SJ; Glasier, C; Kaushik, C; Milesi-Hallé, A; Sharp, GB | 1 |
| Shimizu, T | 1 |
| Hsiao, YC; Yang, JY; Yang, SY | 1 |
2 review(s) available for methylprednisolone and verapamil
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[New treatments for cluster headache].
Topics: Administration, Intranasal; Calcium Channel Blockers; Cluster Headache; Deep Brain Stimulation; Dexamethasone; Humans; Injections, Subcutaneous; Methylprednisolone; Nerve Block; Oxazolidinones; Oxygen Inhalation Therapy; Sumatriptan; Tryptamines; Vagus Nerve Stimulation; Verapamil | 2013 |
2 trial(s) available for methylprednisolone and verapamil
| Article | Year |
|---|---|
[Treatment of bronchial asthma by intrapulmonary administration of steroid hormones and calcium antagonists].
Topics: Adult; Asthma; Bronchodilator Agents; Calcium Channel Blockers; Female; Glucocorticoids; Humans; Male; Methylprednisolone; Middle Aged; Verapamil | 1990 |
Prophylactic treatment of episodic cluster headache with intravenous bolus of methylprednisolone.
Topics: Adult; Cluster Headache; Drug Administration Schedule; Drug Therapy, Combination; Ergotamine; Humans; Injections, Intravenous; Male; Methylprednisolone; Middle Aged; Prednisone; Secondary Prevention; Sumatriptan; Treatment Outcome; Verapamil | 2003 |
36 other study(ies) available for methylprednisolone and verapamil
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Novel experimental parameters to quantify the modulation of absorptive and secretory transport of compounds by P-glycoprotein in cell culture models of intestinal epithelium.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Blotting, Western; Cells, Cultured; Diffusion; Humans; Intestinal Absorption; Intestinal Mucosa; Models, Biological; Permeability; Pharmaceutical Preparations; Pharmacokinetics | 2003 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Surface activity profiling of drugs applied to the prediction of blood-brain barrier permeability.
Topics: Blood-Brain Barrier; Lipid Bilayers; Micelles; Permeability; Pharmaceutical Preparations; Structure-Activity Relationship; Surface Properties | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
First-principle, structure-based prediction of hepatic metabolic clearance values in human.
Topics: Computational Biology; Drug Discovery; Hepatocytes; Humans; Hydrogen-Ion Concentration; Liver; Metabolic Clearance Rate; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship; Sensitivity and Specificity; Software | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Attenuation of intestinal absorption by major efflux transporters: quantitative tools and strategies using a Caco-2 model.
Topics: Adenosine; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Sub-Family B Member 4; ATP-Binding Cassette Transporters; Biological Transport; Caco-2 Cells; Chromatography, Liquid; Dibenzocycloheptenes; Diketopiperazines; Drug Discovery; Heterocyclic Compounds, 4 or More Rings; Humans; Intestinal Absorption; Mass Spectrometry; Models, Biological; Neoplasm Proteins; Pharmaceutical Preparations; Predictive Value of Tests; Propionates; Quinolines; Substrate Specificity | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Comparison of cryopreserved HepaRG cells with cryopreserved human hepatocytes for prediction of clearance for 26 drugs.
Topics: Cell Line, Tumor; Cryopreservation; Female; Hepatocytes; Humans; Male; Metabolic Clearance Rate; Pharmaceutical Preparations; Predictive Value of Tests | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Pharmacological protection of mitochondrial function in hypoxic heart muscle: Effect of verapamil, propranolol, and methylprednisolone.
Topics: Animals; Calcium; Hypoxia; In Vitro Techniques; Male; Methylprednisolone; Mitochondria, Heart; Oxidative Phosphorylation; Propranolol; Rabbits; Verapamil | 1978 |
[A further case of malignant hyperpyrexia and its treatment with lidocaine, methylprednisolone and verapamil (iproveratril) (author's transl)].
Topics: Acidosis; Adult; Calcium; Cryotherapy; Glucose; Halothane; Humans; Insulin; Lidocaine; Male; Malignant Hyperthermia; Methylprednisolone; Muscle Relaxants, Central; Oxygen; Succinylcholine; Verapamil | 1976 |
[The treatment of bronchial asthma patients with intrapulmonary injections of metipred and finoptin using a needle jet injector].
Topics: Adult; Asthma; Bronchodilator Agents; Female; Glucocorticoids; Humans; Injections, Intralesional; Injections, Intramuscular; Injections, Intravenous; Injections, Jet; Lung; Male; Methylprednisolone; Middle Aged; Verapamil | 1990 |
Prevention of detrimental effect of cyclosporin A on vascular ingrowth of transplanted pancreatic islets with verapamil.
Topics: Animals; Cyclosporins; Islets of Langerhans; Male; Methylprednisolone; Mice; Mice, Inbred BALB C; Microscopy, Fluorescence; Verapamil | 1989 |
In vitro studies of ways to overcome resistance to VAMP--high dose melphalan in the treatment of multiple myeloma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cell Survival; Colony-Forming Units Assay; Daunorubicin; Doxorubicin; Drug Resistance; Humans; Melphalan; Methylprednisolone; Multiple Myeloma; Tumor Cells, Cultured; Tumor Stem Cell Assay; Verapamil; Vincristine | 1989 |
The proliferative T-lymphocyte response to streptokinase.
Topics: Adult; Aminophylline; Antibody-Dependent Cell Cytotoxicity; Cells, Cultured; Cyclosporins; Dose-Response Relationship, Drug; Fetal Blood; Humans; Infant, Newborn; Kinetics; Lymphocyte Activation; Methylprednisolone; Streptokinase; T-Lymphocytes; T-Lymphocytes, Regulatory; Verapamil | 1986 |
Myocardial preservation during anoxic arrest. Premedication with propranolol, verapamil or methylprednisolone.
Topics: Animals; Constriction; Dogs; Electric Stimulation; Electrocardiography; Heart; Heart Arrest, Induced; Methylprednisolone; Myocardial Contraction; Premedication; Propranolol; Ventricular Fibrillation; Verapamil | 1983 |
Involvement of angiotensin II in development of spontaneous nephrosis in Dahl salt-sensitive rats.
Topics: Aging; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Body Weight; Calcium Channel Blockers; Cholesterol; Glucocorticoids; Hypertension; Imidazoles; Imidazolidines; Losartan; Male; Methylprednisolone; Nephrosis; Proteinuria; Rats; Rats, Inbred Dahl; Sodium Chloride, Dietary; Verapamil | 1998 |
Corticosteroid-induced acute mania during a cluster headache episode.
Topics: Acute Disease; Adolescent; Age of Onset; Antimanic Agents; Bipolar Disorder; Cluster Headache; Glucocorticoids; Humans; Male; Methylprednisolone; Middle Aged; Valproic Acid; Vasodilator Agents; Verapamil | 2001 |
Secretory transport of methylprednisolone possibly mediated by P-glycoprotein in Caco-2 cells.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Caco-2 Cells; Cell Membrane Permeability; Humans; Methylprednisolone; Verapamil | 2002 |
[Influence of rhinologic usual and unusual drugs on fibroblasts from nasal polyps in cell culture].
Topics: Administration, Topical; Adrenergic beta-Antagonists; Androstadienes; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Beclomethasone; Calcium Channel Blockers; Cells, Cultured; Culture Media; Diclofenac; Fibroblasts; Fluticasone; Glucocorticoids; Hematologic Agents; Humans; In Vitro Techniques; Mesalamine; Methylprednisolone; Mometasone Furoate; Muscarinic Agonists; Nasal Polyps; Pentoxifylline; Pilocarpine; Piroxicam; Prednisolone; Pregnadienediols; Time Factors; Timolol; Verapamil | 2003 |
Polyarteritis nodosa and hypertrophic obstructive cardiomyopathy. A true association?
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathy, Hypertrophic; Cyclophosphamide; Drug Therapy, Combination; Echocardiography; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Polyarteritis Nodosa; Treatment Outcome; Verapamil | 2004 |
Involvement of P-gp in the process of apoptosis in peripheral blood mononuclear cells.
Topics: Adult; Antibodies, Monoclonal; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cortisone; Dexamethasone; Female; Humans; In Vitro Techniques; Leukocytes, Mononuclear; Male; Methotrexate; Methylprednisolone; Middle Aged; Phytohemagglutinins; Verapamil | 2005 |
Limited interaction between tacrolimus and P-glycoprotein in the rat small intestine.
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Calcium Channel Blockers; Cardiotonic Agents; Cyclosporine; Digoxin; Immunosuppressive Agents; Intestinal Absorption; Intestine, Small; Jejunum; Methylprednisolone; Progesterone; Rats; Tacrolimus; Verapamil; Vinblastine | 2006 |
Cutaneous allodynia during cluster headache attacks.
Topics: Adult; Anti-Inflammatory Agents; Cluster Headache; Female; Functional Laterality; Humans; Hyperesthesia; Male; Methylprednisolone; Middle Aged; Skin; Vasodilator Agents; Verapamil | 2009 |
Overlapping features of eclampsia and postpartum angiopathy.
Topics: Adult; Cerebrovascular Disorders; Eclampsia; Female; Headache; Humans; Methylprednisolone; Nicardipine; Postpartum Period; Pregnancy; Puerperal Disorders; Retrospective Studies; Seizures; Stroke; Subarachnoid Hemorrhage; Vasoconstriction; Vasodilator Agents; Verapamil; Young Adult | 2009 |
Variable manifestations of familial hemiplegic migraine associated with reversible cerebral edema in children.
Topics: Adolescent; Anti-Inflammatory Agents; Brain Edema; Calcium Channel Blockers; Calcium Channels; Child; Cognition Disorders; DNA; Electroencephalography; Female; Functional Laterality; Gait Disorders, Neurologic; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Methylprednisolone; Migraine with Aura; Neurologic Examination; Sodium-Potassium-Exchanging ATPase; Verapamil | 2012 |
Comparison of combination therapy (steroid, calcium channel blocker, and interferon) with steroid monotherapy for treating human hypertrophic scars in an animal model.
Topics: Adult; Animals; Calcium Channel Blockers; Cicatrix, Hypertrophic; Disease Models, Animal; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Interferons; Male; Methylprednisolone; Mice; Mice, Nude; Middle Aged; Verapamil | 2015 |